DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 29 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2016$2,547,000
+64.6%
172,3070.0%0.12%
+93.4%
Q2 2016$1,547,000
-2.9%
172,3070.0%0.06%
-10.3%
Q1 2016$1,594,000
-26.6%
172,3070.0%0.07%
-22.7%
Q4 2015$2,173,000
-3.2%
172,3070.0%0.09%
+1.1%
Q3 2015$2,245,000
-40.3%
172,3070.0%0.09%
-30.4%
Q2 2015$3,760,000
-17.8%
172,307
-23.8%
0.12%
-15.5%
Q1 2015$4,573,000226,0640.15%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Endurant Capital Management LP 206,800$36,314,0008.27%
Fairmount Funds Management LLC 886,281$15,563,0005.66%
FRAZIER MANAGEMENT LLC 3,123,107$54,984,0004.40%
ACT CAPITAL MANAGEMENT, LLC 466,000$8,183,0004.24%
RAMIUS ADVISORS LLC 338,042$5,936,0003.54%
Western Standard LLC 265,355$4,660,0002.65%
HAVENS ADVISORS LLC 109,000$1,914,0002.30%
Crabel Capital Management, LLC 423,490$7,436,0002.29%
S. MUOIO & CO. LLC 160,000$2,810,0002.16%
Omni Partners US LLC 2,366,824$41,561,0002.13%
View complete list of TRILLIUM THERAPEUTICS INC shareholders